http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012004726-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_25438d8faca272da1d28f57627fc1f55
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-525
filingDate 2011-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0110ae33aa62558cbe2e824c295fc2f0
publicationDate 2012-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2012004726-A1
titleOfInvention Trans-epithelial osmotic collyrium for the treatment of keratoconus
abstract Trans-epithelial osmotic collyrium for the treatment of keratoconus by corneal cross-linking with UV rays, of the type consisting of a riboflavin- based solution and an absorption enhancement adjuvant consisting of benzalkonium chloryde (BAC). The solution has a hypoosmolarity degree ranging between -70% and -30% over an isotonic solution and contains a BAC concentration accordingly ranging between 0.005% and 0.035%.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9020580-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10028657-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10258809-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11406805-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10350111-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9498122-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9498114-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11642244-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8574277-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9498642-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IT-RM20130248-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11167149-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11766356-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11219553-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9707126-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8870934-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014174544-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9044308-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11179576-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11207410-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10137239-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10114205-B2
priorityDate 2010-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010023705-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2253321-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393816
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127461181
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127461182
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID493570
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6759
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127965299
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421126
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5411
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399047

Total number of triples: 51.